Dr. Akira Watanabe
Reproductive Medicine Specialist · Founder, BetterFreeze
Leads clinical strategy, cross-border coordination, and ensures CDC/SART benchmarks stay accurate for every profile.
Data & Research
How we verify, interpret, and publish fertility data—for transparency and understanding.
We don’t collect data to market; we collect it to clarify.
What data we use
We source fertility statistics from U.S. public databases to ensure every comparison is verifiable.
Primary sources:
- CDC ART Success Rates Database (latest: 2023 cycle)
- SART Clinic Reports (participating clinics)
- Verified clinic disclosures and coordinator confirmations
These data form the foundation of every clinic profile on BetterFreeze.
How we process data
Every dataset goes through a three-step process to ensure accuracy and clarity:
Verification
Cross-checked against CDC/SART records and clinic disclosures.
Normalization
Aligned by comparable indicators (e.g., success rate per embryo transfer).
Annotation
Reviewed by clinicians with notes that explain what the numbers mean.
This process turns raw data into context patients can actually understand.
Why we publish these data
Transparency is not our goal—it’s our method.
By showing how outcomes differ by clinic or program, we help patients understand the system itself.
We believe understanding is the first step toward freedom of choice in fertility care.
Example: U.S. national IVF outcomes (2023)
The chart below illustrates how success rates vary by treatment type and age group.
- Fresh IVF
- Frozen embryo transfer
- Donor egg
| Age band | Fresh IVF | Frozen embryo transfer | Donor egg |
|---|---|---|---|
| Under 35 | |||
| 35–37 | |||
| 38–40 |
Live birth rate (%)
Each figure is verified and standardized using CDC definitions.
Independence & Ethics
We don’t sell ad placement or ranking positions.
We don’t alter or omit clinic data for commercial reasons.
Our reviews and annotations are made under clinical supervision.
BetterFreeze operates independently to protect the integrity of data and trust of users.
Clinical Oversight
All data verification and interpretation are overseen by:
Molly Chu-Chen
Lead Embryologist · 25+ years lab experience
Oversees lab data integrity, embryo outcomes, and patient education across U.S. and Asia networks.
Advisory Members
Japan Society for Reproductive Medicine & ASRM collaborators
Provide peer review and ethical guidance on methodology, benchmarks, and publication standards.
Want to understand what these numbers mean for your plan?
Book a free bilingual consultation—our coordinators will translate data into practical guidance within 24 hours.